-
In order to accelerate transformation, traditional pharmaceutical companies and Biotech cooperation mergers and acquisitions have become the norm!
Time of Update: 2023-02-02
js?cdnversion='+~(-new Date()/36e5)];Recently, another traditional pharmaceutical company and Biotech announced a merger and acquisition!
js?cdnversion='+~(-new Date()/36e5)];Recently, another traditional pharmaceutical company and Biotech announced a merger and acquisition!
js?cdnversion='+~(-new Date()/36e5)];Recently, another traditional pharmaceutical company and Biotech announced a merger and acquisition!
-
International Frontier, Normative Leading HCC International Frontier and Norm Summit Forum was successfully held
Time of Update: 2023-01-06
Chapter 2: Normative Guidance Professor Cui Zilin of Tianjin First Central Hospital reviewed the initial exploration of atezolizumab and bevacizumab in the theme report "Past, present and future of systematic treatment of advanced liver cancer", sorted out the course of atezolizumab + bevacizumab (T+A protocol) in the collaborative fight against HCC, and shared a series of exploratory research new progress, describing the future of atezolizumab + bevacizumab, including MO42541, TALENTACE, IMbrave 050, ABC-HCC and TALENTOP studies, among others.
-
International Frontier, Normative Leading HCC International Frontier and Norm Summit Forum was successfully held
Time of Update: 2023-01-06
Chapter 2: Normative Guidance Professor Cui Zilin of Tianjin First Central Hospital reviewed the initial exploration of atezolizumab and bevacizumab in the theme report "Past, present and future of systematic treatment of advanced liver cancer", sorted out the course of atezolizumab + bevacizumab (T+A protocol) in the collaborative fight against HCC, and shared a series of exploratory research new progress, describing the future of atezolizumab + bevacizumab, including MO42541, TALENTACE, IMbrave 050, ABC-HCC and TALENTOP studies, among others.
-
bases, and investment of 100 million yuan has become the norm
Time of Update: 2022-12-30
With the wave of innovation in the pharmaceutical industry, many enterprises are accelerating projects such as building new R&D production bases in order to improve profitability, enhance innovative
-
PP market weak downward price reduction transaction or become the norm
Time of Update: 2022-12-09
Petrochemical price stabilization has limited support for market supply costs, and the low volatility of futures has hit market confidence, and traders' quotations have been slightly reduced.
-
Aluminum industry norms, standards and interpretation
Time of Update: 2022-12-01
In order to accelerate the structural adjustment of the aluminum industry, standardize the order of production and operation of enterprises, curb the disorderly expansion of aluminum smelting capacity
-
Pharmaceutical companies are adopting a contraction strategy, and frequent asset sales are the norm
Time of Update: 2022-11-26
Judging from public information, Harbour Pharmaceutical's business adjustment actions have been very frequent in the past two months, not only selling factories, but also two core products under research have been terminated and sold respectively.
-
Nature: Challenge the norm! The higher the viscosity of the extracellular fluid, the easier
Time of Update: 2022-11-26
These authors reveal physical cues about how cells sense and respond to increased viscosity, and how the cytoskeleton, which controls cell shape and intracellular structure and participates in cell movement, works with ion channels and ion transporters--- protein --- that guide charged molecules through the cell membrane to regulate efficient migration at high viscosities.
-
For pharmaceutical companies that are keen on "buying, buying, buying", the failure of acquisitions has become the norm
Time of Update: 2022-11-11
Regarding the reasons for terminating the acquisition, Clarion said that due to regulatory reasons, the company and Snapdragon have not yet agreed on future development plans and countermeasures.
-
The wave of financing in the pharmaceutical field is still continuing, and the financing amount exceeding 100 million yuan has become the norm
Time of Update: 2022-10-25
, an innovative company in the field of neuromodulation in China, announced (hereinafter referred to as "Shenwok Medical") that it has successfully completed nearly 100 million yuan of Series B financing.
-
Archives Management Norms Scientific Research" standards were released and implemented from October 1
Time of Update: 2022-09-21
Scientific Research on Ecological Environment Archives Management NormsIt was formulated in order to implement the "Environmental Protection Law of the People's Republic of China" and the "Archives Law of the People's Republic of China", improve the management level of archives for ecological and environmental scientific research, promote the standardization, scientificization and institutionalization of scientific research archives, and give full play to the value of ecological and environmental research archives in the cause of ecological environmental protection.
-
Shanghai implements the "Long-term Prescription Management Norms (Trial)"
Time of Update: 2022-09-21
District Health Commissions, Medical Insurance Bureaus, Shenkang Hospital Development Center, relevant universities, The China Welfare Association, the Shanghai Municipal Health Commission Supervisio
-
Make breastfeeding the norm
Time of Update: 2022-09-20
Experts said that comprehensively carrying out social publicity, strengthening health education for target groups, and popularizing the core essentials of breastfeeding will have an effective impact on improving the family support rate for breastfeeding .
-
Make breastfeeding the norm
Time of Update: 2022-09-20
Experts said that comprehensively carrying out social publicity, strengthening health education for target groups, and popularizing the core essentials of breastfeeding will have an effective impact on improving the family support rate for breastfeeding .
-
become the norm! The pharmaceutical company reduced its staff by more than 2,300 people in half a year
Time of Update: 2022-09-09
For example, on August 19, Hengrui Pharmaceutical released a semi-annual report showing that the company's sales staff in the first half of this year decreased by more than 2,300 people.